CTRP12 ameliorates post-myocardial infarction heart failure through down-regulation of cardiac apoptosis, oxidative stress and inflammation by influencing the TAK1-p38 MAPK/JNK pathway

ConclusionsCTRP12 protects against post-MI HF by modulating the TAK1-p38 MAPK/JNK pathway. CTRP12 may be a therapeutic target for the treatment of post-MI HF.

http://link.springer.com/10.1007/s00011-023-01758-4

Source: Inflammation Research - June 29, 2023 Category: Research Source Type: research